Results 71 to 80 of about 2,243,245 (285)

Real‐World Experience With Multimodal Treatment of Resectable Stage II–III Non‐Small Cell Lung Cancer: A Single Institutional Analysis

International Journal of Cancer, EarlyView.
ABSTRACT Neoadjuvant therapy has recently become an integral component of multimodal treatment for resectable lung cancer. However, real‐world data on perioperative morbidity and treatment adherence remain limited. This study aimed to assess the feasibility and safety of different neoadjuvant treatment approaches applied within daily clinical routine ...
Raffaella Griffo, Benedikt Niedermaier, Laura V. Klotz, Marc Schneider, Michael Allgäuer, Marc Kriegsmann, Romina M. Roesch, Lena Brendel, Henrike Deissner, Farastuk Bozorgmehr, Petros Christopoulos, Michael Thomas, Hauke Winter, Martin E. Eichhorn, Florian Eichhorn   +14 more
wiley   +1 more source

DataSheet_1_Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion.pdf

, 2023
Platelet concentrate (PC) transfusion seeks to provide haemostasis in patients presenting severe central thrombocytopenia or severe bleeding. PCs may induce adverse reactions (AR) that can occasionally be severe (SAR).
Amélie Prier (15301624), Anne-Claire Duchez (683627), Sébastien Fauteux-Daniel (15301612), Fabrice Cognasse (78451), Theo Ebermeyer (15301618), Justine Bertrand-Michel (76337), Charles-Antoine Arthaud (630773), Marco Heestermans (142187), Estelle Audoux (11816081), Hind Hamzeh-Cognasse (78447), Marie-Ange Eyraud (15301621), Bernard Payrastre (127787), Caroline Sut (15301615), Olivier Garraud (78450), Eric Boilard (683632)   +14 more
core   +1 more source

Impact of Cell Saver technology on pro‐hemostatic factors transfusion in placenta accreta spectrum interventions: A 10‐year retrospective single‐center study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background While Cell Saver technology effectively reduces red blood cell transfusion in the perioperative setting, its impact on the need for pro‐hemostatic factors remains unclear. The use of Cell Saver could impact the requirements of pro‐hemostatic factors.
Ilan Levy, Maud Vachette, Emma Van Der Putten, Marine Chouteau, François Goffinet, Catherine Fischer, Aude Girault, Yoann Athiel   +7 more
wiley   +1 more source

Evaluating and Optimising the Retrieval of Research Evidence for Systematic Reviews of Adverse Drug Effects and Adverse Drug Reactions [PDF]

, 2013
Systematic reviews can provide timely, reliable evidence on which to make informed decisions. In order to make balanced decisions, information is not only needed on the benefits of an intervention, but also on its adverse effects.
Golder, Su
core   +4 more sources

Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Ascelia‐Manganese‐Based MRI Contrast Agent (ACE‐MBCA) in Adult Subjects With and Without Hepatic Impairment

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Orally administered Ascelia‐manganese‐based contrast agent (ACE‐MBCA) is used for liver MRI, but its feasibility in patients with hepatic dysfunction remains unknown. Purpose To investigate the pharmacokinetics (PK), pharmacodynamics, and safety of ACE‐MBCA in subjects without/with hepatic impairment.
Amit G. Singal, Eric Lawitz, Andreas Norlin, Nadilka Hettiarachchige, Thomas Bengtsson, Bachir Taouli   +5 more
wiley   +1 more source

Monitoring adverse blood transfusion reactions at a tertiary care hospital in Haryana: A haemovigilance study

National Journal of Physiology, Pharmacy and Pharmacology
Background: Hemovigilance stands as a fundamental necessity for the safe transfusion practice. It is an essential component of quality management in transfusion.
Anugya Kushwaha, Vinod Kumar Bhardwaj, Pawan Singh, Naveen Kumar, Navin Budania, Siddharth Ahuja   +5 more
doaj   +1 more source

Recipient hemovigilance at a tertiary care hospital in Southern India: A cross-sectional study

International Journal of Advanced Medical and Health Research, 2018
Introduction: Information on incidence of various transfusion reactions could help in early recognition as well as management and could also help to institute adequate measures to make blood transfusion as safe as possible.
Vikram Kumar Gente, Abhishekh Basavarajegowda, Rajendra Kulkarni, Debdatta Basu   +3 more
doaj   +1 more source

The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm.

Blood transfusion = Trasfusione del sangue, 2013
Transfusion therapy remains the main treatment for patients with severe haemoglobinopathies, but can cause adverse reactions which may be classified as immediate or delayed. The use of targeted prevention with drugs and treatments of blood components in selected patients can contribute to reducing the development of some reactions.The aim of our study ...
Francesco, Bennardello, Carmelo, Fidone, Vincenzo, Spadola, Sergio, Cabibbo, Simone, Travali, Giovanni, Garozzo, Agostino, Antolino, Giuseppe, Tavolino, Cadigia, Falla, Pietro, Bonomo   +9 more
openaire   +2 more sources

Incidence of Adverse Transfusion Reaction and Practices for its Prevention

Haematology International Journal, 2021
Transfusion reactions are the untoward event towards blood products. Although majority of transfusion reactions are uneventful sometimes it may have life threatening events. This study was conducted to estimate the incidence and determine the nature of blood transfusion reactions in our hospital.
openaire   +1 more source

Nudix hydrolase 15 deficiency and azathioprine toxicity in a liver transplant recipient: A case report

JPGN Reports, EarlyView.
Abstract Thiopurines, such as azathioprine (AZA), are among the immunosuppressants used to prevent allograft rejection. Thiopurines are metabolized by thiopurine S‐methyltransferase (TPMT) and nudix hydrolase 15 (NUDT15) enzymes, and their functions are highly influenced by genetic variation. We present a 6‐year‐old female with recurrent acute cellular
Jenny Q. Nguyen, Natalie Rodriguez, Kimberly A. Chapman, Matthew A. Deardorff, Keith Z. Hazleton   +4 more
wiley   +1 more source